Characteristic | Patients (%) | CR (%) | NO CR (%) | p value |
---|---|---|---|---|
Age | ||||
 <60 years | 30 (90.9) | 23 (76.7) | 7 (23.3) | 1.000 |
 ≥ 60 years | 3 (9.1) | 2 (66.7) | 1 (33.3) |  |
Gender | ||||
 Male | 19 (57.6) | 16 (84.2) | 3 (15.8) | 0.238 |
 Female | 14 (42.2) | 9 (64.3) | 5 (35.7) |  |
Primary site | ||||
 UNKTCL | 30 (90.9) | 23 (76.7) | 7 (23.3) | 1.000 |
 EUNKTCL | 3 (9.1) | 2 (66.7) | 1 (33.3) |  |
An Arbor Stage | ||||
 I~II | 21 (63.6) | 19 (90.5) | 2 (9.5) | 0.015* |
 III~IV | 12 (36.4) | 6 (50.0) | 6 (50.0) |  |
B symptom | ||||
 Yes | 12 (36.4) | 9 (75.0) | 3 (25.0) | 1.000 |
 No | 21 (63.6) | 16 (76.2) | 5 (23.8) |  |
ECOG | ||||
 0–1 | 27 (81.8) | 21 (77.8) | 6 (22.2) | 0.616 |
 ≥ 2 | 6 (18.2) | 4 (66.7) | 2 (33.3) |  |
LDH | ||||
 Increased | 7 (21.2) | 2 (28.6) | 5 (71.4) | 0.004* |
 Normal | 26 (78.8) | 23 (88.5) | 3 (11.5) |  |
IPI score | ||||
 0~ 1 | 22 (66.7) | 21 (95.5) | 1 (4.5) | < 0.001* |
 ≥ 2 | 11 (33.3) | 4 (36.4) | 7 (63.6) |  |
β2-microglobulin | ||||
 Increased | 8 (24.2) | 5 (62.5) | 3 (37.5) | 0.366 |
 Normal | 25 (75.8) | 20 (80.0) | 5 (20.0) |  |
BM involvement | ||||
 Yes | 4 (12.1) | 3 (75.0) | 1 (25.0) | 1.000 |
 No | 29 (87.9) | 22 (75.9) | 7 (24.1) |  |
Lymph node involvement | ||||
 Yes | 12 (36.4) | 9 (75.0) | 3 (25.0) | 1.000 |
 No | 21 (63.6) | 16 (76.2) | 5 (23.8) |  |
Extranodal involvement site | ||||
 0–1 | 26 (78.8) | 22 (84.6) | 4 (15.4) | 0.042 |
 ≥ 2 | 7 (21.2) | 3 (42.9) | 4 (57.1) |  |
Allergy history | ||||
 Yes | 1 (3.0) | 0 (0.0) | 1 (100.0) | 0.242 |
 No | 32 (97.0) | 25 (78.1) | 7 (21.9) |  |